http://articles.mercola.com/sites/articles/archive/2000/12/10/diabetes-drug-part-one.aspxPeople who have diabetic neuropathy do not appear to benefit from a synthetic version of human nerve growth factor (rhNGF), according to a new study. Researchers compared 418 patients who received injections of rhNGF three times a week for 48 weeks withenCommunityServer 2008.5 SP1 (Build: 31106.3070)